Seyss C, Foote E F
Department of Pharmacy Practice and Administration, College of Pharmacy, Rutgers, State University of New Jersey, Piscataway 08855, USA.
Ann Pharmacother. 1995 Feb;29(2):187-8. doi: 10.1177/106002809502900216.
Because of both an absence of sufficient data and the concern for increased toxicity in certain patient populations, the use of CCBs to reduce radiocontrast-associated nephrotoxicity is not recommended. Additional prospective, randomized trials are needed.
由于缺乏足够的数据以及对某些患者群体中毒性增加的担忧,不建议使用钙通道阻滞剂来降低放射性造影剂相关的肾毒性。还需要更多前瞻性、随机试验。